Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 167,990
  • Shares Outstanding, K 79,616
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,770 K
  • 60-Month Beta 0.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.42
Trade SLNO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.17
  • Growth Rate Est. (year over year) +58.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.85 +10.81%
on 12/29/20
2.31 -11.29%
on 01/13/21
+0.15 (+7.89%)
since 12/24/20
3-Month
1.50 +36.67%
on 10/30/20
2.31 -11.29%
on 01/13/21
+0.20 (+10.81%)
since 10/23/20
52-Week
1.30 +57.69%
on 03/18/20
4.39 -53.30%
on 05/21/20
-1.59 (-43.68%)
since 01/24/20

Most Recent Stories

More News
Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that management will present...

SLNO : 2.05 (-2.84%)
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced the receipt of official...

SLNO : 2.05 (-2.84%)
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and...

SLNO : 2.05 (-2.84%)
Soleno Therapeutics Announces Presentation of Body Composition Results from DESTINY PWS, a Phase III Trial of DCCR in Prader-Willi Syndrome

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentation of body composition...

SLNO : 2.05 (-2.84%)
Soleno Therapeutics Announces Late-Breaking Oral Presentation with Body Composition Results from Phase III DESTINY PWS Trial of DCCR in Prader-Willi Syndrome at ObesityWeek(R) 2020 Meeting

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that body composition data...

SLNO : 2.05 (-2.84%)
Soleno Therapeutics' Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Soleno Therapeutics.

SLNO : 2.05 (-2.84%)
Soleno Therapeutics Announces Updated Top-line Results from Phase III Trial of DCCR for Treatment of Prader-Willi Syndrome

Updated Results Demonstrate Significant DCCR Exposure Response Relationship

SLNO : 2.05 (-2.84%)
Soleno Therapeutics to Participate in Fireside Chat at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D.,...

MHMNF : 54.5000 (unch)
SLNO : 2.05 (-2.84%)
Soleno (SLNO) in Focus: Stock Moves 6.3% Higher

Soleno (SLNO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

PCRX : 69.80 (+2.86%)
SLNO : 2.05 (-2.84%)
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and...

SLNO : 2.05 (-2.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 2.19
2nd Resistance Point 2.16
1st Resistance Point 2.10
Last Price 2.05
1st Support Level 2.01
2nd Support Level 1.98
3rd Support Level 1.92

See More

52-Week High 4.39
Fibonacci 61.8% 3.21
Fibonacci 50% 2.84
Fibonacci 38.2% 2.48
Last Price 2.05
52-Week Low 1.30

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar